Brief: Akari Therapeutics Appoints Melissa Bradford-Klug As Chief Operating Officer
13/06/2022 12:37
June 13 (Reuters) - Akari Therapeutics PLC AKTX.O :
* AKARI THERAPEUTICS ANNOUNCES THE APPOINTMENT OF
ACCOMPLISHED
BIOTECH EXECUTIVE MELISSA BRADFORD-KLUG AS CHIEF OPERATING
OFFICER TO LEAD BUSINESS DEVELOPMENT AND COMPANY GROWTH
STRATEGIES
Source text for Eikon: ID:nGNX1yGJNc
Further company coverage: AKTX.O
((Reuters.Briefs@thomsonreuters.com;))